CloudLinux Releases Imunify360 v3 with Improved Malware Blocking Capabilities
PALO ALTO, CA. (PRWEB) March 14, 2018 -- CloudLinux, the maker of the leading Web server security and stability solutions for hosting providers, has announced the release of Imunify360 version 3.0. It now blocks 10 times more of malicious IPs compared to the version released in March 2017.
Imunify360 includes significant improvements such as faster malware scans, better detection of new malware, and four times more of WAF rules. Imunify360 now receives four million security-related events each day with an eightfold decrease in false positives.
“We have made tremendous improvements in Imunify360 since it was first released a year ago,” said Igor Seletskiy, CloudLinux CEO. “Based on the feedback collected from our customers, as well as a substantial technological development, our team is able to ensure that Imunify360 delivers great Web server protection to our customers.”
Imunify360 is the next-generation security solution built for Linux VPS, Dedicated, and Shared servers. It is powered by AI and uses herd immunity and the six-layer approach to provide total protection against attacks. It includes key security features such as advanced firewall, malware scanning (antivirus), IDS/IPS protection, reputation management, and much more, all integrated into customer’s control panel.
Imunify360 runs on CentOS 6 and 7, RHEL 6 and 7, and CloudLinux OS 6 and 7 distributions. It supports cPanel and Plesk control panels. Imunify360 is free for nonprofit organizations.
For more information on Imunify360, and for pricing, visit Imunify360.com.
About CloudLinux
CloudLinux is on a mission to make Linux secure, stable, and profitable. With more than 4,000 customers and partners, including LiquidWeb and Dell, and more than 200,000 product installations, CloudLinux combines in-depth technical knowledge of hosting, kernel development, and open source with unique client care expertise.
Inna Gordin, Cloud Linux Inc, http://cloudlinux.com, +1 9739518266, [email protected]
Share this article